二特异性抗体疗法 二特异性抗体疗法
Luiz Henrique de Assis1, Daniel El Fassi2, Martin Hutchings2,3
1Unidade de Terapia Celular, Hospital São Rafael, Salvador, Bahia, Brasil.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
针对血液癌症的双特异性抗体 (BsAbs) 导致常见的血液毒性. 早期治疗中性质衰竭和低型球蛋白血症是减少患者伤害的关键.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 癌症治疗正在转向针对性药物和免疫疗法,如双特异性抗体 (BsAbs).
- 这些先进疗法具有独特且潜在的严重副作用.
- 与BsAbs相关的血液毒性需要全面的审查和管理策略.
研究的目的:
- 审查与双特异抗体 (BsAbs) 相关的血液毒性.
- 提出基于证据的建议,用于管理这些新型治疗相关的副作用.
- 解决有关新兴免疫疗法副作用概况的文献上的差距.
主要方法:
- 对已发表的关于血液性恶性瘤双特异抗体 (BsAb) 治疗的文献进行系统审查.
- 报告的血液学毒性及其临床影响的分析.
- 综合数据,制定管理准则.
主要成果:
- 血液学毒性是BsAbs.的频繁且显著的副作用.
- 虽然很少见,但可能会出现诸如血细胞性淋巴细胞结核和扩散性血管内凝血等疾病.
- 严重的中性质衰竭和低型球蛋白血症是常见的,但可以通过及时干预来控制.
结论:
- 血液毒性是双特异抗体 (BsAb) 治疗的主要问题.
- 积极管理和预防中性质衰竭和低血糖球蛋白血症的策略至关重要.
- 有效的管理可以减轻与BsAb诱导的血液毒性相关的发病率和死亡率.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Hybridoma Technology
14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K
Cross-reactivity
31.1K
Overview
31.1K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Special Features of Adaptive Immunity
829
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
829


